Dermatology News

Alphyn Biologics presented interim data from the second cohort of its phase 2a clinical trial program of AB-101a for the treatment of atopic dermatitis, according to a presentation at the Society for Pediatric Dermatology annual meeting.

Once-daily crisaborole ointment 2% may be an effective and well-tolerated long-term maintenance therapy for pediatric and adult patients with mild to moderate atopic dermatitis, according to a study.

Alphyn Biologics announced new data from its phase 2a clinical trial evaluating topical AB-101a for the treatment of mild to moderate atopic dermatitis in patients aged as young as 2 years, according to a company release.

Protection from the sun, heat and air pollution is important to keeping children healthy while they spend more time outside this summer, the AAP said this week as it announced tips for preventing illnesses related to outdoor activities.

A 3-year-old girl came running into her house, crying loudly with pain in her right hand. Her mother noticed several flat red marks, but no break in the skin, and she assumed they were insect bites or stings.

Clinicians should consider rubella virus as a potential contributor to granulomatous skin disease in both immunodeficient and immunocompetent patients, according to a study.

Newborns of mothers with alopecia areata experienced a significantly greater risk for developing alopecia and accompanying comorbidities, according to a study.

A 16-month-old girl presents with a painful neck mass and fever. Her mother states that she has always had a “fullness” in the front of her neck, which suddenly increased in size.

The second of two phase 3 studies evaluating Vtama cream 1% in adults and children aged as young as 2 years with atopic dermatitis showed consistent safety and efficacy results, Dermavant Sciences announced in a press release.

There is not yet enough evidence to adequately assess the benefit-harm balance of screening for skin cancer in asymptomatic adolescents and adults, according to a statement from the U.S. Preventive Services Task Force.